Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factors

Por Igarashi, Tomoyuki, Teramoto, Koji, Ishida, Mitsuaki, Hanaoka, Jun, Daigo, Yataro
Publicado no ESMO Open (2016)

International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries

Por Liede, Alexander, Hallett, David C, Hope, Kirsty, Graham, Alex, Arellano, Jorge, Shahinian, Vahakn B
Publicado no ESMO Open (2016)

Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study

Por Gutzmer, R, Rivoltini, L, Levchenko, E, Testori, A, Utikal, J, Ascierto, P A, Demidov, L, Grob, J J, Ridolfi, R, Schadendorf, D, Queirolo, P, Santoro, A, Loquai, C, Dreno, B, Hauschild, A, Schultz, E, Lesimple, T P, Vanhoutte, N, Salaun, B, Gillet, M, Jarnjak, S, De Sousa Alves, P M, Louahed, J, Brichard, V G, Lehmann, F F
Publicado no ESMO Open (2016)

Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort

Por Bonneterre, Jacques, Bosq, Jacques, Jamme, Philippe, Valent, Alexander, Gilles, Erard M, Zukiwski, Alexander A, Fuqua, Suzanne A W, Lange, Carol A, O'Shaughnessy, Joyce
Publicado no ESMO Open (2016)

Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers

Por Berghoff, Anna S, Schur, Sophie, Füreder, Lisa M, Gatterbauer, Brigitte, Dieckmann, Karin, Widhalm, Georg, Hainfellner, Johannes, Zielinski, Christoph C, Birner, Peter, Bartsch, Rupert, Preusser, Matthias
Publicado no ESMO Open (2016)

Association between bevacizumab-related hypertension and response to treatment in patients with metastatic colorectal cancer

Por Dionísio de Sousa, Isabel José, Ferreira, Joana, Rodrigues, Joana, Bonito, Nuno, Jacinto, Paula, Marques, Mariela, Ribeiro, João, Pais, Ana, Gervásio, Helena
Publicado no ESMO Open (2016)

Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use program...

Por Sforza, Vincenzo, Martinelli, Erika, Cardone, Claudia, Martini, Giulia, Napolitano, Stefania, Vitiello, Pietro Paolo, Vitale, Pasquale, Zanaletti, Nicoletta, Reginelli, Alfonso, Bisceglie, Maurizio Di, Latiano, Tiziana Pia, Bochicchio, Anna Maria, Cecere, Fabiana, Selvaggi, Francesco, Ciardiello, Fortunato, Troiani, Teresa
Publicado no ESMO Open (2017)

Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma

Por Merle, Philippe, Camus, Philippe, Abergel, Armand, Pageaux, Georges Philippe, Masliah, Claude, Bronowicki, Jean Pierre, Zarski, Jean Pierre, Pelletier, Gilles, Bouattour, Mohamed, Farloux, Laetitia, Dorval, Etienne, verset, Gilles, Si-Ahmed, Si-Nafa, Doffoel, Michel, Couzigou, Patrice, Taieb, Julien, Vasseur, Bérangère, Attali, Pierre
Publicado no ESMO Open (2017)

Anti-PD-1/anti-PD-L1 immunotherapy versus docetaxel for previously treated advanced non-small cell lung cancer: a systematic review and meta-analysis of randomised clinical trials

Por Ramos-Esquivel, Allan, van der Laat, Alicia, Rojas-Vigott, Raquel, Juárez, Melissa, Corrales-Rodríguez, Luis
Publicado no ESMO Open (2017)

Patient-reported pain severity, pain interference and health status in HR+/HER2− advanced/metastatic breast cancer

Por Wood, Robert, Mitra, Debanjali, de Courcy, Jonathan, Iyer, Shrividya
Publicado no ESMO Open (2017)

Proxies of quality of life in metastatic colorectal cancer: analyses in the RECOURSE trial

Por Van Cutsem, Eric, Falcone, Alfredo, Garcia-Carbonero, Rocio, Komatsu, Yoshito, Pastorino, Alessandro, Peeters, Marc, Shimada, Yasuhiro, Yamazaki, Kentaro, Yoshino, Takayuki, Zaniboni, Alberto, Amellal, Nadia, Kanehisa, Akira, Winkler, Robert, Makris, Lukas, Mayer, Robert J, Ohtsu, Atsushi, Tabernero, Josep
Publicado no ESMO Open (2017)

TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma

Por Leduc, Charlotte, Adam, Julien, Louvet, Emilie, Sourisseau, Tony, Dorvault, Nicolas, Bernard, Marine, Maingot, Elodie, Faivre, Laura, Cassin-Kuo, Mei-Shiue, Boissier, Emilie, Dessoliers, Marie-Charlotte, Robin, Angélique, Casiraghi, Odile, Even, Caroline, Temam, Stéphane, Olaussen, Ken A, Soria, Jean-Charles, Postel-Vinay, Sophie
Publicado no ESMO Open (2018)

Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management

Por Geukes Foppen, Marnix H, Rozeman, Elisa A, van Wilpe, Sandra, Postma, Cindy, Snaebjornsson, Petur, van Thienen, Johannes V, van Leerdam, Monique E, van den Heuvel, Michel, Blank, Christian U, van Dieren, Jolanda, Haanen, John B A G
Publicado no ESMO Open (2018)

Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical case

Por Martinelli, Erika, Troiani, Teresa, Sforza, Vincenzo, Martini, Giulia, Cardone, Claudia, Vitiello, Pietro Paolo, Ciardiello, Davide, Rachiglio, Anna Maria, Normanno, Nicola, Sartore-Bianchi, Andrea, Marsoni, Silvia, Bardelli, Alberto, Siena, Salvatore, Ciardiello, Fortunato
Publicado no ESMO Open (2018)

Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas

Por Fiedler, Walter, Cresta, Sara, Schulze-Bergkamen, Henning, De Dosso, Sara, Weidmann, Jens, Tessari, Anna, Baumeister, Hans, Danielczyk, Antje, Dietrich, Bruno, Goletz, Steffen, Zurlo, Alfredo, Salzberg, Marc, Sessa, Cristiana, Gianni, Luca
Publicado no ESMO Open (2018)

Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours

Por Moore, Kathleen N, Bauer, Todd M, Falchook, Gerald S, Chowdhury, Swapan, Patel, Chirag, Neuwirth, Rachel, Enke, Aaron, Zohren, Fabian, Patel, Manish R
Publicado no ESMO Open (2018)

Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small c...

Por Oizumi, Satoshi, Sugawara, Shunichi, Minato, Koichi, Harada, Toshiyuki, Inoue, Akira, Fujita, Yuka, Maemondo, Makoto, Watanabe, Satoshi, Ito, Kazuhiko, Gemma, Akihiko, Demura, Yoshiki, Fukumoto, Shinichi, Isobe, Hiroshi, Kinoshita, Ichiro, Morita, Satoshi, Kobayashi, Kunihiko, Hagiwara, Koichi, Aiba, Keisuke, Nukiwa, Toshihiro
Publicado no ESMO Open (2018)

Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma

Por Lim, Kok Haw Jonathan, Spain, Lavinia, Barker, Claire, Georgiou, Alexandros, Walls, Gerard, Gore, Martin, Turajlic, Samra, Board, Ruth, Larkin, James M, Lorigan, Paul
Publicado no ESMO Open (2018)

Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan

Por Funakoshi, Taro, Horimatsu, Takahiro, Nakamura, Michio, Shiroshita, Koichi, Suyama, Koichi, Mukoyama, Masashi, Mizukami, Takuro, Sakurada, Tsutomu, Baba, Eishi, Tsuruya, Kazuhiko, Nozaki, Akira, Yahata, Kensei, Ozaki, Yukinori, Ubara, Yoshifumi, Yasui, Hisateru, Yoshimoto, Akihiro, Fukuma, Shingo, Kondo, Naoya, Matsubara, Takeshi, Matsubara, Kazuo, Fukuhara, Shunichi, Yanagita, Motoko, Muto, Manabu
Publicado no ESMO Open (2018)

Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability

Por Cho, Junhun, Chang, Young Hwan, Heo, You Jeong, Kim, Seungtae, Kim, Nayoung KD, Park, Joon Oh, Kang, Won Ki, Lee, Jeeyun, Kim, Kyoung-Mee
Publicado no ESMO Open (2018)